| Literature DB >> 28713851 |
Joseph M Labuz1,2, Christopher Moraes3, David R Mertz1,2, Brendan M Leung4,5, Shuichi Takayama1,2,6,7.
Abstract
New advances in engineering and biomedical technology have enabled recent efforts to capture essential aspects of human physiology in microscale, in-vitro systems. The application of these advances to experimentally model complex processes in an integrated platform - commonly called a 'human-on-a-chip (HOC)' - requires that relevant compartments and parameters be sized correctly relative to each other and to the system as a whole. Empirical observation, theoretical treatments of resource distribution systems and natural experiments can all be used to inform rational design of such a system, but technical and fundamental challenges (e.g. small system blood volumes and context-dependent cell metabolism, respectively) pose substantial, unaddressed obstacles. Here, we put forth two fundamental principles for HOC design: inducing in-vivo-like cellular metabolic rates is necessary and may be accomplished in-vitro by limiting O2 availability and that the effects of increased blood volumes on drug concentration can be mitigated through pharmacokinetics-based treatments of solute distribution. Combining these principles with natural observation and engineering workarounds, we derive a complete set of design criteria for a practically realizable, physiologically faithful, five-organ millionth-scale (× 10-6) microfluidic model of the human body.Entities:
Keywords: C. aceratus; Human on a Chip; Metabolic Scaling; Microfluidics; Organ on a Chip; Oxygen Conformance
Year: 2017 PMID: 28713851 PMCID: PMC5509033 DOI: 10.1142/S2339547817500029
Source DB: PubMed Journal: Technology (Singap World Sci)